As of April 16, 2025, C4 Therapeutics (CCCC) has a market cap of $84.478 million USD. According to our data, C4 Therapeutics is ranked No.7704 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $84.48 M |
-66.76%
|
Dec 31, 2024 | $0.25 B |
-36.28%
|
Dec 29, 2023 | $0.40 B |
-4.24%
|
Dec 30, 2022 | $0.42 B |
-81.68%
|
Dec 31, 2021 | $2.27 B |
-2.81%
|
Dec 31, 2020 | $2.34 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Arvinas
ARVN
|
$0.52 B |
0.000 M
|
![]() USA
|
![]() Nurix Therapeutics
NRIX
|
$0.75 B |
0.000 M
|
![]() USA
|
![]() Kymera Therapeutics
KYMR
|
$1.65 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
Market Cap | = | CCCC Stock Price | * | CCCC Shares Outstanding |
= | $1.19 | * | 70.99 M | |
= | $84.48 M |